RT Journal Article
SR Electronic
T1 P-038 Predictors of ventriculostomy infection in a large cohort
JF Journal of NeuroInterventional Surgery
JO J NeuroIntervent Surg
FD BMJ Publishing Group Ltd.
SP A46
OP A46
DO 10.1136/neurintsurg-2019-SNIS.74
VO 11
IS Suppl 1
A1 Sweid, A
A1 Tjoumakaris, S
A1 Wamsley, C
A1 Mann, E
A1 Neely, C
A1 Head, J
A1 Gooch, M
A1 Herial, N
A1 Alexander, T
A1 Missios, S
A1 Chalouhi, N
A1 Rosenwasser, R
A1 Jabbour, P
YR 2019
UL http://jnis.bmj.com/content/11/Suppl_1/A46.2.abstract
AB Background External ventricular drain (EVD) placement is a common neurosurgical procedure. While this procedure is simple and effective, infection is a major limiting factor. Factors predictive of infection reported in the literature are not conclusive.Objective The aim of this retrospective single-center large sample was to assess the rate and factors predictive of infection.Methods We performed a retrospective review of patients who underwent EVD placement between January 2012 and January 2018.Results A total of 714 patients were included in the study. The infection rate was 3.6% (26/714). In 45% of the cases, the indication for ventriculostomy placement was for acute subarachnoid hemorrhage (aSAH) or intracerebral hemorrhage (ICH). Of the factors that were an independently significant predictor of ventriculostomy-associated infection (VAI) was the placement of a second EVD; the likelihood was eight times higher than if only a single EVD was placed (OR: 7.95, 95% CI: 1.01–62.9, p<0.05). Another factor was routine CSF sampling, associated with greater than nine times higher likelihood of VAI compared to no routine CSF sampling (OR: 9.20, 95% CI: 1.93–43.9, p<0.01). Intrathecal (IT) drug deliveries were also associated with a higher likelihood of VAI (OR: 55.7, 95%CI: 2.92-1060, p<0.01). Non-significant factors were day vs. night, location (ICU/ER vs. OR), duration, CSF leak, suture type, system flushing.Conclusion Our study shows that the rate of VAI was 3.6%. Only three variables were significant independent predictors of VAI; these were the replacement of the EVD, routine CSF aspiration, and intrathecal drug delivery.Disclosures A. Sweid: None. S. Tjoumakaris: None. C. Wamsley: None. E. Mann: None. C. Neely: None. J. Head: None. M. Gooch: None. N. Herial: None. T. Alexander: None. S. Missios: None. N. Chalouhi: None. R. Rosenwasser: None. P. Jabbour: None.